Gyre Therapeutics Inc. (GYRE)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.46B
EV to revenue ratio (TTM)
4.01
EV to ebitda
131
Financial Performance
Revenue (TTM)
$0.11B
Gross profit (TTM)
$0.10B
EBITDA
-$0.02B
Profitability
Operating margin (TTM)
-4.46%
Profit margin
-22.70%
Return on assets (TTM)
-6.32%
Return on equity (TTM)
-17.20%
Per Share Metrics
Revenue per share (TTM)
$1.13
EPS
-$0.31
Diluted EPS (TTM)
-$0.31
Book value
$1.01
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
188.68
PEG ratio
n/a
Price to sales ratio (TTM)
4.21
Price to book ratio (TTM)
4.70
Growth
Quarterly earnings growth (YoY)
0.70%
Quarterly revenue growth (YoY)
166.20%
Analyst Sentiment
Strong buy
0
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
4.92